XBiotech Inc.

NasdaqGS:XBIT Stock Report

Market Cap: US$272.8m

XBiotech Management

Management criteria checks 3/4

XBiotech's CEO is John Simard, appointed in Mar 2005, has a tenure of 19.08 years. total yearly compensation is $4.67M, comprised of 18.9% salary and 81.1% bonuses, including company stock and options. directly owns 21.71% of the company’s shares, worth $59.24M. The average tenure of the management team and the board of directors is 6.4 years and 7 years respectively.

Key information

John Simard

Chief executive officer

US$4.7m

Total compensation

CEO salary percentage18.9%
CEO tenure19.1yrs
CEO ownership21.7%
Management average tenure6.4yrs
Board average tenure7yrs

Recent management updates

Recent updates

We're Not Very Worried About XBiotech's (NASDAQ:XBIT) Cash Burn Rate

Feb 09
We're Not Very Worried About XBiotech's (NASDAQ:XBIT) Cash Burn Rate

We're Hopeful That XBiotech (NASDAQ:XBIT) Will Use Its Cash Wisely

Oct 25
We're Hopeful That XBiotech (NASDAQ:XBIT) Will Use Its Cash Wisely

We Think Some Shareholders May Hesitate To Increase XBiotech Inc.'s (NASDAQ:XBIT) CEO Compensation

Jun 16
We Think Some Shareholders May Hesitate To Increase XBiotech Inc.'s (NASDAQ:XBIT) CEO Compensation

XBiotech (NASDAQ:XBIT) Is In A Good Position To Deliver On Growth Plans

May 11
XBiotech (NASDAQ:XBIT) Is In A Good Position To Deliver On Growth Plans

Read This Before Buying XBiotech Inc. (NASDAQ:XBIT) Shares

Mar 18
Read This Before Buying XBiotech Inc. (NASDAQ:XBIT) Shares

Here's Why We Don't Think XBiotech's (NASDAQ:XBIT) Statutory Earnings Reflect Its Underlying Earnings Potential

Jan 08
Here's Why We Don't Think XBiotech's (NASDAQ:XBIT) Statutory Earnings Reflect Its Underlying Earnings Potential

XBiotech's influenza-COVID-19 therapeutic cocktail shows effective anti-virus activity

Nov 19

CEO Compensation Analysis

How has John Simard's remuneration changed compared to XBiotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$25m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$28m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$5mUS$881k

-US$33m

Sep 30 2022n/an/a

-US$36m

Jun 30 2022n/an/a

-US$27m

Mar 31 2022n/an/a

-US$20m

Dec 31 2021US$8mUS$777k

-US$17m

Sep 30 2021n/an/a

-US$13m

Jun 30 2021n/an/a

-US$12m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020US$3mUS$684k

-US$11m

Sep 30 2020n/an/a

US$677m

Jun 30 2020n/an/a

US$673m

Mar 31 2020n/an/a

US$674m

Dec 31 2019US$11mUS$591k

US$669m

Sep 30 2019n/an/a

-US$24m

Jun 30 2019n/an/a

-US$23m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018US$1mUS$585k

-US$21m

Sep 30 2018n/an/a

-US$22m

Jun 30 2018n/an/a

-US$23m

Mar 31 2018n/an/a

-US$27m

Dec 31 2017US$702kUS$566k

-US$33m

Compensation vs Market: John's total compensation ($USD4.67M) is above average for companies of similar size in the US market ($USD1.60M).

Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.

CEO

John Simard (61 yo)

19.1yrs

Tenure

US$4,670,934

Compensation

Mr. John Simard is the Founder of XBiotech, Inc. and serves as its Chairman and has been its Chief Executive Officer and President since March 2005. Mr. Simard serves as the Chairman, Chief Executive Offic...

Leadership Team

NamePositionTenureCompensationOwnership
John Simard
Founder19.1yrsUS$4.67m21.71%
$ 59.2m
Sushma Shivaswamy
Chief Scientific Officer6.4yrsUS$381.24k0%
$ 0
Angela Hu
Director of Finance1.2yrsno data0.084%
$ 228.5k

6.4yrs

Average Tenure

45yo

Average Age

Experienced Management: XBIT's management team is seasoned and experienced (6.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
John Simard
Founder19.1yrsUS$4.67m21.71%
$ 59.2m
W. McKenzie
Independent Director15.2yrsUS$174.48k8.45%
$ 23.0m
Donald MacAdam
Independent Director6.1yrsUS$171.98k0.033%
$ 89.6k
Peter Libby
Member of Scientific Advisory Board & Independent Director5.6yrsUS$151.98k0.082%
$ 224.0k
Alice Gottlieb
Member of Scientific Advisory Board5.6yrsno datano data
Alexander Knuth
Member of Scientific Advisory Board7yrsno datano data
Razelle Kurzrock
Member of Scientific Advisory Board7yrsno datano data
Andrew Hendifar
Member of Scientific Advisory Board7yrsno datano data
Jan-Paul Waldin
Lead Independent Director6.2yrsUS$179.48k0.66%
$ 1.8m
Evangelos Giamarellos-Bourboulis
Member of Scientific Advisory Boardno datano datano data
Mark Rupp
Member of Scientific Advisory Boardno datano datano data

7.0yrs

Average Tenure

74yo

Average Age

Experienced Board: XBIT's board of directors are considered experienced (7 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.